Decision Support System as method for transforming Healthcare inside out! - Enterprise Viewpoint

Specialty drugs account for just 2% of all medicines prescribed, yet they are on pace to comprise 50% of the drug spend in the next few years – ballooning to $400B in the US alone by 2020. Traditional approaches to drug utilization and cost management are simply not working. And biopharmaceutical pipelines are filled with new, high-priced, specialty drugs that continue to pressure health care budgets around the world. There is currently estimated to be up to $20billion in annual, solvable Specialty Rx inefficiencies in the US alone. By identifying which drugs are most effective for which patients (precision analytics for precision medicine) can a Decision support system (DSS) help solve the growing problem with Specialty Drug Use and Cost out of Control? This trend is unsustainable to the healthcare system.